In today’s recent session, 1.03 million shares of the Elanco Animal Health Inc (NYSE:ELAN) have been traded, and its beta is 1.61. Most recently the company’s share price was $13.09, and it changed around $0.43 or 3.39% from the last close, which brings the market valuation of the company to $6.50B. ELAN at last check was trading at a discount to its 52-week high of $18.80, offering almost -43.62% off that amount. The share price’s 52-week low was $8.02, which indicates that the recent value has risen by an impressive 38.73% since then. We note from Elanco Animal Health Inc’s average daily trading volume that its 10-day average is 5.98 million shares, with the 3-month average coming to 5.74 million.
Elanco Animal Health Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.80. If we narrow it down even further, the data shows that 0 out of 16 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 8 recommended ELAN as a Hold, whereas 6 deemed it a Buy, and 0 rated it as Underweight.
Elanco Animal Health Inc (NYSE:ELAN) trade information
Instantly ELAN has been showing a green trend so far today with a performance of 3.39% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 13.38 on recent trading dayincreased the stock’s daily price by 2.17%. The company’s shares are currently up 8.09% year-to-date, but still down -0.98% over the last five days. On the other hand, Elanco Animal Health Inc (NYSE:ELAN) is 38.37% up in the 30-day period. We can see from the shorts that 24.81 million shares have been sold at a short interest cover period of 4.09 day(s).
The consensus price target as assigned by Wall Street analysts is $12, which translates to bulls needing to decrease their stock price by -9.08% from its current value. Analyst projections state that ELAN is forecast to be at a low of $11 and a high of $18.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 29.95%. Elanco Animal Health Inc earnings are expected to increase by -8.08% in 2025, but the outlook is positive 5.75% per year for the next five years.
ELAN Dividends
Elanco Animal Health Inc’s next quarterly earnings report is expected to be released on 2025-May-06.
Elanco Animal Health Inc (NYSE:ELAN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.03% of Elanco Animal Health Inc shares, and 101.43% of them are in the hands of institutional investors. The stock currently has a share float of 102.49%. Elanco Animal Health Inc stock is held by 501.0 institutions, with DODGE & COX being the largest institutional investor. By 2024-06-30, it held 16.9128% of the shares, which is about 83.58 million shares worth $1.21 billion.
PRIMECAP MANAGEMENT CO/CA/, with 10.6845% or 52.8 million shares worth $761.94 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Dodge & Cox Funds-Dodge & Cox Stock Fund and VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 55.34 shares worth $722.76 million, making up 11.14% of all outstanding shares. On the other hand, VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund held roughly 18.98 shares worth around $247.86 million, which represents about 3.82% of the total shares outstanding.
